OSUR OraSure Technologies Inc.

OraSure Technologies Earnings Conference Call Invitation

OraSure Technologies Earnings Conference Call Invitation

2020 First Quarter Earnings Conference Call 

Wednesday, May 6, 2020, 5:00 p.m. ET

BETHLEHEM, Pa., April 09, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 first quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 6, 2020. 

May 6, 2020 Schedule
 
4:01 p.m. ET2020 first quarter financial results press release will be distributed.
  
4:50 p.m. ETTo participate in the conference call, dial 844-831-3030 (Domestic) or 315-625-6887 (International) and reference Conference ID # 5498040
  
5:00 p.m. ETConference call and simultaneous Webcast begins.

The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure’s website, .  Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.

If you are unable to participate, a replay of the call will be archived on OraSure’s website shortly after the call has ended and will be available for seven days.  A replay of the call can also be accessed until midnight, May 13, 2020 by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering the Conference ID # 5498040.

COMPANY CONTACT: Joni Messenlehner, OraSure Technologies, Inc. 610-882-1820, or .

EN
09/04/2020

Underlying

OSUROraSure Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OraSure Technologies Inc.

 PRESS RELEASE
Free
OSUR OraSure Technol...

OraSure Announces Second Quarter 2025 Financial Results

OraSure Announces Second Quarter 2025 Financial Results BETHLEHEM, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2025. “Our Q2 results were consistent with our expectations. We are making significant progress on our initiatives to expand our product portfolio, including launching our novel blood collection device for proteomic research in July. We are also staying closely aligned with our custome...

August 5, 2025 1 EN
 PRESS RELEASE
Free
OSUR OraSure Technol...

OraSure Appoints Anne Messing as Chief Commercial Officer

OraSure Appoints Anne Messing as Chief Commercial Officer BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Commercial Officer. Ms. Messing brings more than 25 years of commercial leadership experience across the healthcare industry, including in life sciences, diagnostics, and clinical laboratory services, with a proven track record of driving growth, building high-performing sales teams, and tra...

August 4, 2025 1 EN
 PRESS RELEASE
Free
OSUR OraSure Technol...

OraSure to Announce Second Quarter 2025 Financial Results and Host Ear...

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business developments for 5 p.m. ET on August 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webca...

July 21, 2025 1 EN
 PRESS RELEASE
Free
OSUR OraSure Technol...

OraSure Launches Novel Blood Collection Device for Proteomic Research

OraSure Launches Novel Blood Collection Device for Proteomic Research The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for research BETHLEHEM, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the launch of its HEMAcollect™●PROTEIN product to meet the evolving needs of proteomic researchers. The product, developed by OTI subsidiary DNA Genotek, is an evacuated blood colle...

July 10, 2025 1 EN
 PRESS RELEASE
Free
OSUR OraSure Technol...

OraSure Announces First Quarter 2025 Financial Results

OraSure Announces First Quarter 2025 Financial Results BETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025. “Our Q1 results were consistent with our expectations. Our customers continue to demonstrate their preference for our differentiated products in delivering on their important health objectives, even while uncertainty remains elevated related to government funding sources for some ...

May 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch